Skip to content

Advertisement

  • Poster presentation
  • Open Access

ELCID: early lung cancer identification and diagnosis - an embedded interview study to explore patient participation and recruitment

  • 1,
  • 2,
  • 3,
  • 3,
  • 4,
  • 5,
  • 6,
  • 7,
  • 8,
  • 9,
  • 9,
  • 3,
  • 3,
  • 3 and
  • 1
Trials201314 (Suppl 1) :P102

https://doi.org/10.1186/1745-6215-14-S1-P102

  • Published:

Keywords

  • Lung Cancer
  • Eligibility Criterion
  • Usual Care
  • Preliminary Finding
  • Research Nurse

Background

The ELCID Trial is a feasibility randomised controlled trial examining the effect on lung cancer diagnosis of giving an urgent chest x-ray to smokers, and recent ex-smokers, aged over 60 with new chest symptoms.

Aims

The qualitative component explores the feasibility of individually randomising patients to an urgent CXR or not and investigates any barriers to patient participation.

Methods

To date we have conducted semi-structured interviews with six primary care staff (practice managers, research nurses), ten patients randomised to ‘extra-NICE' guidelines for referral for urgent chest x-ray, and six patients randomised to ‘usual care' (NICE guidelines)). We hope to also interview patients who decline randomisation. Interviews were analysed using a Framework approach.

Results

Initial analysis indicated that practices have struggled to recruit patients, partly due to the eligibility criteria that requires ex-smokers to have stopped smoking within the last five years. Practices with a research nurse have recruited the most patients. Patients indicated that they are happy to take part in the trial and their anxiety levels were not raised. Most patients hoped to be randomised to urgent chest x-ray, although those who were not did not go back to their GP to request one.

Conclusions

Eligibility criteria needed revision to include ex-smokers of any duration. These preliminary findings suggest that the trial appears to be feasible and patients are happy to accept randomisation. The findings will inform the design of the main trial in the future.

Authors’ Affiliations

(1)
Marie Curie Palliative Care Research Centre, Wales Cancer Trials Unit, Cardiff University, Cardiff, UK
(2)
North Wales Centre for Primary Care Research, College of Health & Behavioural Sciences, Bangor University, Wrexham, UK
(3)
Wales Cancer Trials Unit, Cardiff University, Cardiff, UK
(4)
Doncaster Royal Infirmary, Doncaster, UK
(5)
University of Exeter Medical School, Exeter, UK
(6)
Centre for Economics and Policy in Health, Bangor University, Bangor, UK
(7)
Centre for Health and Social Care Research, Sheffield Hallam University, Sheffield, UK
(8)
Wrexham Maelor Hospital, Wrexham, UK
(9)
South East Wales Trials Unit, Cardiff University, Cardiff, UK

Copyright

© Prout et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement